Oppenheimer Upgrades Incyte to Outperform, Raises Price Target to $144
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsUpgradesPrice Target
Oppenheimer analyst Jay Olson upgrades Incyte (NASDAQ:INCY) from Perform to Outperform and raises the price target from $120 to $144.
Oppenheimer analyst Jay Olson upgrades Incyte (NASDAQ:INCY) from Perform to Outperform and raises the price target from $120 to $144.